Clinical trial
A Randomized, Double-Blind, Placebo and Active Comparator-Controlled Study of DS-5565 for Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT01496365 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo and Active Comparator-Controlled Study of DS-5565 for Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
- Lead sponsor
- Daiichi Sankyo
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 28, 2011
- Completion date
- September 7, 2012
- Enrollment
- 452 (actual)
- Sites
- 78
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic peripheral neuropathy